♥

Wanbury Limited

ISIN : INE107F01022
NSE : WANBURY
BSE : 524212
Face Value : 10
Industry : Pharmaceuticals & Drugs

EPS : 16.89
EPS (TTM) : 15.77
Price to Earning (P/E) : 13.88
Book Value : 6.44
Price to Bookvalue (P/B) : 36.40
Dividend Yield : 0 %
Return on Equity (ROE) : %
Return on Capital Employed (ROCE) : 101.15 %

Wanbury Limited share price (02-Apr-2026)
National Stock Exchange NSE
Open / Close	0 - 0 NAN %
Low / High	0 - 0 NAN %
Trade Volume	0
52 Week Low / High	0 - 0 NAN %
Bombay Stock Exchange BSE
Open / Close	230 - 230.4 0.2 %
Low / High	223.6 - 230.4 3 %
Trade Volume	1,478
52 Week Low / High	162 - 330 103.7 %

YOU MAY ALSO LIKE

How much money do you need to retire
Know how much money do you need to retire, before how much to invest ?
CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator
High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE
Share Market basics for beginners
Share Market jargons in simple terms
Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE
Stock market course tutorial
Stock Market Investment Course explained in simple words.

Consolidated Standalone

CONSOLIDATED QUARTERLY RESULT FOR WANBURY LIMITED

Date End	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
No of months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months
Net Sales	1343.94	1169.4	1239.55	1257.77	1329.75	1462.85	1444.62	1454.97	1394.06	1311.08
Total Income	1350.35	1188.75	1247.36	1260.36	1309.14	1469.02	1452.18	1461.89	1403.31	1320.53
Total Expenditure	1215.8	1199.84	1183.59	1193.21	1188.12	1329.37	1271.18	1243.51	1212.43	1201.34
Other Income	6.41	19.35	7.8	2.59	-20.62	6.17	7.56	6.93	9.25	9.45
Operating Profit	134.55	-11.09	63.77	67.15	121.02	139.65	181	218.38	190.88	119.19
Interest	47.9	33.09	39.35	66.34	75.15	57.89	76.71	82.6	74.6	75.93
Exceptional Items	763.68				-5.94				255.57
PBDT	850.33	-44.18	24.42	0.81	39.93	81.76	104.29	135.78	371.85	43.26
Depreciation	30.02	30.34	31.52	31.26	30.73	31.85	32.43	33.23	32.8	32.89
Profit Before Tax	820.31	-74.52	-7.1	-30.45	9.2	49.91	71.86	102.55	339.05	10.37
Tax	-5.14	-2.07	1.8	2.32	-0.95	3.02	-1.76	-0.17	2.72
Profit After Tax	825.45	-72.45	-8.9	-32.77	10.15	46.89	73.62	102.72	336.33	10.37
Net Profit	825.45	-72.45	-8.9	-32.77	10.15	46.89	73.62	102.72	336.33	10.37
Equity Capital	326.66	326.96	326.96	327.05	327.06	327.06	327.36	327.46	327.46	327.46
Face Value (IN RS)	10	10	10	10	10	10	10	10	10	10
Calculated EPS	25.27	-2.22	-0.27	-1	0.31	1.43	2.25	3.14	10.27	0.32
Diluted Eps After Extraordinary Items	25.54	-2.22	-0.27	-1	0.31	1.43	2.25	3.13	10.08	0.31
Diluted Eps Before Extraordinary Items	25.54	-2.22	-0.27	-1	0.31	1.43	2.25	3.13	10.08	0.31

STANDALONE QUARTERLY RESULT FOR WANBURY LIMITED

Date End	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
No of months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months
Net Sales	1343.94	1169.4	1239.55	1257.77	1329.75	1462.85	1444.62	1454.97	1394.06	1311.08
Total Income	1350.35	1188.75	1247.35	1260.36	1309.14	1469.02	1452.18	1461.89	1403.31	1320.53
Total Expenditure	1215.81	1199.84	1183.59	1193.21	1188.12	1329.37	1271.18	1243.51	1212.43	1201.34
Other Income	6.41	19.35	7.8	2.59	-20.62	6.17	7.56	6.93	9.25	9.45
Operating Profit	134.54	-11.09	63.76	67.15	121.02	139.65	181	218.38	190.88	119.19
Interest	47.89	33.09	39.35	66.34	75.15	57.89	76.71	82.6	74.6	75.93
Exceptional Items	763.68				-5.94
PBDT	850.33	-44.18	24.41	0.81	39.93	81.76	104.29	135.78	116.28	43.26
Depreciation	30.02	30.34	31.51	31.26	30.73	31.85	32.43	33.23	32.8	32.89
Profit Before Tax	820.31	-74.52	-7.1	-30.45	9.2	49.91	71.86	102.55	83.48	10.37
Tax	-5.14	-2.07	1.8	2.32	-0.95	3.02	-1.76	-0.17	2.72
Profit After Tax	825.45	-72.45	-8.9	-32.77	10.15	46.89	73.62	102.72	80.76	10.37
Net Profit	825.45	-72.45	-8.9	-32.77	10.15	46.89	73.62	102.72	80.76	10.37
Equity Capital	326.66	326.96	326.95	327.05	327.06	327.06	327.36	327.46	327.46	327.46
Face Value (IN RS)	10	10	10	10	10	10	10	10	10	10
Calculated EPS	25.27	-2.22	-0.27	-1	0.31	1.43	2.25	3.14	2.47	0.32
Diluted Eps After Extraordinary Items	25.54	-2.22	-0.27	-1	0.31	1.43	2.25	3.13	2.37	0.31
Diluted Eps Before Extraordinary Items	25.54	-2.22	-0.27	-1	0.31	1.43	2.25	3.13	2.37	0.31

Consolidated Standalone

CONSOLIDATED ANNUAL RESULT FOR WANBURY LIMITED

Date End	Mar 2022	Mar 2023	Mar 2024
No of months	12 months	12 months	12 months
Net Sales	5111.86	4996.47	5756.5
Total Income	5126.94	5005.6	5786.4
Total Expenditure	4758.73	4764.75	5056.47
Other Income	15.08	9.13	29.9
Operating Profit	368.21	240.85	729.93
Interest	206.11	213.94	291.81
Exceptional Items	763.68	-5.94	255.57
PBDT	925.78	20.97	693.69
Depreciation	114.5	123.85	130.31
Profit Before Tax	811.28	-102.88	563.38
Tax	-3.46	1.09	3.81
Profit After Tax	814.74	-103.97	559.57
Net Profit	814.74	-103.97	559.57
Equity Capital	326.66	327.06	327.46
Face Value (IN RS)	10	10	10
Reserves	-560.85	-655.22	-48.04
Calculated EPS	24.94	-3.18	17.09
Diluted Eps After Extraordinary Items	25.21	-3.18	16.89
Diluted Eps Before Extraordinary Items	25.21	-3.18	16.89

STANDALONE ANNUAL RESULT FOR WANBURY LIMITED

Date End	Mar 2022	Mar 2023	Mar 2024
No of months	12 months	12 months	12 months
Net Sales	5111.86	4996.47	5756.5
Total Income	5126.94	5005.6	5786.4
Total Expenditure	4758.73	4764.75	5056.47
Other Income	15.08	9.13	29.9
Operating Profit	368.21	240.85	729.93
Interest	206.11	213.94	291.81
Exceptional Items	763.68	-5.94
PBDT	925.78	20.97	438.12
Depreciation	114.5	123.85	130.31
Profit Before Tax	811.28	-102.88	307.81
Tax	-3.46	1.09	3.81
Profit After Tax	814.74	-103.97	304
Net Profit	814.74	-103.97	304
Equity Capital	326.66	327.06	327.46
Face Value (IN RS)	10	10	10
Reserves	-304.78	-399.65	-48.04
Calculated EPS	24.94	-3.18	9.28
Diluted Eps After Extraordinary Items	25.21	-3.18	9.18
Diluted Eps Before Extraordinary Items	25.21	-3.18	9.18

Consolidated Standalone

CONSOLIDATED PROFIT / LOSS FOR WANBURY LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Gross Sales	394.42 Cr	514.56 Cr	509.22 Cr	580.82 Cr
Sales	389 Cr	510.62 Cr	507.75 Cr	579.65 Cr
Net Sales	392.52 Cr	511.19 Cr	499.65 Cr	575.65 Cr
Increase/Decrease in Stock	-7.2 Cr	-24.79 Cr	29.13 Cr	-3.89 Cr
Raw Material Consumed	224.35 Cr	325.07 Cr	273.46 Cr	306.52 Cr
Opening Raw Materials	3.57 Cr	8.98 Cr	9 Cr	10.41 Cr
Purchases Raw Materials	219.11 Cr	304.95 Cr	258.89 Cr	299.31 Cr
Closing Raw Materials	8.98 Cr	9 Cr	10.41 Cr	20.5 Cr
Other Direct Purchases / Brought in cost	10.65 Cr	20.14 Cr	15.98 Cr	17.3 Cr
Power & Fuel Cost	17.13 Cr	18.41 Cr	20.59 Cr	24.58 Cr
Electricity & Power	17.13 Cr	18.41 Cr	20.59 Cr	24.58 Cr
Employee Cost	64.15 Cr	74.81 Cr	81 Cr	86.92 Cr
Salaries, Wages & Bonus	57.64 Cr	66.4 Cr	72.31 Cr	77.78 Cr
Contributions to EPF & Pension Funds	4.69 Cr	5.58 Cr	5.46 Cr	6.37 Cr
Workmen and Staff Welfare Expenses	1.62 Cr	2.12 Cr	2.37 Cr	3.31 Cr
Other Manufacturing Expenses	9.98 Cr	12.66 Cr	11.43 Cr	13.32 Cr
Repairs and Maintenance	5.1 Cr	7.08 Cr	5.85 Cr	6.77 Cr
General and Administration Expenses	23.63 Cr	20.58 Cr	23.57 Cr	26.59 Cr
Rent , Rates & Taxes	3.85 Cr	1.93 Cr	1.75 Cr	1.35 Cr
Insurance	99.8 Lk	1.06 Cr	1.26 Cr	1.04 Cr
Professional and legal fees	14.5 Cr	12.28 Cr	13.02 Cr	16.87 Cr
Traveling and conveyance	4.06 Cr	5.1 Cr	7.33 Cr	7.11 Cr
Selling and Distribution Expenses	18.72 Cr	31.31 Cr	21.27 Cr	26.65 Cr
Advertisement & Sales Promotion	2.18 Cr	6.75 Cr	5.09 Cr	10.16 Cr
Sales Commissions & Incentives	5.74 Cr	4.7 Cr	3.98 Cr	4.77 Cr
Freight and Forwarding	10.62 Cr	19.74 Cr	12.17 Cr	11.68 Cr
Miscellaneous Expenses	26.1 Cr	21.4 Cr	16.12 Cr	24.96 Cr
Provision for doubtful debts	0	0	1 Lk	1.08 Cr
Loss on disposal of fixed assets(net)	43.49 Lk	63.05 Lk	6.12 Lk	0
Loss on foreign exchange fluctuations	85.91 Lk	45.33 Lk	67.05 Lk	0
Loss on sale of non-trade current investments	0	40,000	0	0
Total Expenditure	376.85 Cr	479.45 Cr	476.57 Cr	505.65 Cr
Other Income	4.75 Cr	5.09 Cr	1.01 Cr	2.99 Cr
Interest Received	40.19 Lk	66.93 Lk	41.57 Lk	37.64 Lk
Profit on sale of Fixed Assets	0	0	0	27.42 Lk
Provision Written Back	3.99 Cr	3.9 Cr	43.59 Lk	21.87 Lk
Foreign Exchange Gains	0	0	0	2.09 Cr
Operating Profit	20.42 Cr	36.82 Cr	24.09 Cr	72.99 Cr
Interest	23.07 Cr	20.61 Cr	21.39 Cr	29.18 Cr
PBDT	-2.65 Cr	16.21 Cr	2.69 Cr	43.81 Cr
Depreciation	9.75 Cr	11.45 Cr	12.38 Cr	13.03 Cr
Profit Before Taxation & Exceptional Items	-12.41 Cr	4.76 Cr	-9.69 Cr	30.78 Cr
Exceptional Income / Expenses	0	76.37 Cr	-59.38 Lk	25.56 Cr
Profit Before Tax	-12.41 Cr	81.13 Cr	-10.29 Cr	56.34 Cr
Provision for Tax	20 Lk	-34.62 Lk	10.9 Lk	38.1 Lk
Deferred Tax	-2.07 Cr	-34.62 Lk	10.9 Lk	38.1 Lk
Profit After Tax	-12.61 Cr	81.47 Cr	-10.4 Cr	55.96 Cr
Consolidated Net Profit	-12.61 Cr	81.47 Cr	-10.4 Cr	55.96 Cr
Profit Balance B/F	-252.95 Cr	-266 Cr	-183.73 Cr	-193.87 Cr
Appropriations	-265.56 Cr	-184.53 Cr	-194.13 Cr	-137.91 Cr
Other Appropriation	44.11 Lk	-79.53 Lk	-26.08 Lk	59.22 Lk
Earnings Per Share	-5.04	24.94	-3.18	17.09
Adjusted EPS	-5.04	24.94	-3.18	17.09

STANDALONE PROFIT / LOSS FOR WANBURY LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Gross Sales	394.42 Cr	514.57 Cr	509.22 Cr	580.82 Cr
Sales	389 Cr	510.62 Cr	507.75 Cr	579.65 Cr
Net Sales	392.52 Cr	511.19 Cr	499.65 Cr	575.65 Cr
Increase/Decrease in Stock	-7.2 Cr	-24.79 Cr	29.13 Cr	-3.89 Cr
Raw Material Consumed	224.35 Cr	325.07 Cr	273.46 Cr	306.52 Cr
Opening Raw Materials	3.57 Cr	8.98 Cr	9 Cr	10.41 Cr
Purchases Raw Materials	219.11 Cr	304.95 Cr	258.89 Cr	299.31 Cr
Closing Raw Materials	8.98 Cr	9 Cr	10.41 Cr	20.5 Cr
Other Direct Purchases / Brought in cost	10.65 Cr	20.14 Cr	15.98 Cr	17.3 Cr
Power & Fuel Cost	17.13 Cr	18.41 Cr	20.59 Cr	24.58 Cr
Electricity & Power	17.13 Cr	18.41 Cr	20.59 Cr	24.58 Cr
Employee Cost	64.15 Cr	74.81 Cr	81 Cr	86.92 Cr
Salaries, Wages & Bonus	57.64 Cr	66.4 Cr	72.31 Cr	77.78 Cr
Contributions to EPF & Pension Funds	4.69 Cr	5.58 Cr	5.46 Cr	6.37 Cr
Workmen and Staff Welfare Expenses	1.62 Cr	2.12 Cr	2.37 Cr	3.31 Cr
Other Manufacturing Expenses	9.98 Cr	12.66 Cr	11.43 Cr	13.32 Cr
Repairs and Maintenance	5.1 Cr	7.08 Cr	5.85 Cr	6.77 Cr
General and Administration Expenses	23.63 Cr	20.58 Cr	23.57 Cr	26.59 Cr
Rent , Rates & Taxes	3.85 Cr	1.93 Cr	1.75 Cr	1.35 Cr
Insurance	99.8 Lk	1.06 Cr	1.26 Cr	1.04 Cr
Professional and legal fees	14.5 Cr	12.28 Cr	13.02 Cr	16.87 Cr
Traveling and conveyance	4.06 Cr	5.1 Cr	7.33 Cr	7.11 Cr
Selling and Distribution Expenses	18.72 Cr	31.31 Cr	21.27 Cr	26.65 Cr
Advertisement & Sales Promotion	2.18 Cr	6.75 Cr	5.09 Cr	10.16 Cr
Sales Commissions & Incentives	5.74 Cr	4.7 Cr	3.98 Cr	4.77 Cr
Freight and Forwarding	10.62 Cr	19.74 Cr	12.17 Cr	11.68 Cr
Miscellaneous Expenses	26.1 Cr	21.4 Cr	16.12 Cr	24.96 Cr
Provision for doubtful debts	0	0	1 Lk	1.08 Cr
Loss on disposal of fixed assets(net)	43.49 Lk	63.05 Lk	6.12 Lk	0
Loss on foreign exchange fluctuations	85.91 Lk	45.33 Lk	67.05 Lk	0
Loss on sale of non-trade current investments	0	40,000	0	0
Total Expenditure	376.85 Cr	479.45 Cr	476.57 Cr	505.65 Cr
Other Income	4.75 Cr	5.09 Cr	1.01 Cr	2.99 Cr
Interest Received	40.19 Lk	66.93 Lk	41.57 Lk	37.64 Lk
Profit on sale of Fixed Assets	0	0	0	27.42 Lk
Provision Written Back	3.99 Cr	3.9 Cr	43.59 Lk	21.87 Lk
Foreign Exchange Gains	0	0	0	2.09 Cr
Operating Profit	20.42 Cr	36.82 Cr	24.09 Cr	72.99 Cr
Interest	23.07 Cr	20.61 Cr	21.39 Cr	29.18 Cr
PBDT	-2.65 Cr	16.21 Cr	2.69 Cr	43.81 Cr
Depreciation	9.75 Cr	11.45 Cr	12.38 Cr	13.03 Cr
Profit Before Taxation & Exceptional Items	-12.41 Cr	4.76 Cr	-9.69 Cr	30.78 Cr
Exceptional Income / Expenses	0	76.37 Cr	-59.38 Lk	0
Profit Before Tax	-12.41 Cr	81.13 Cr	-10.29 Cr	30.78 Cr
Provision for Tax	20 Lk	-34.62 Lk	10.9 Lk	38.1 Lk
Deferred Tax	-2.07 Cr	-34.62 Lk	10.9 Lk	38.1 Lk
Profit After Tax	-12.61 Cr	81.47 Cr	-10.4 Cr	30.4 Cr
Consolidated Net Profit	-12.61 Cr	81.47 Cr	-10.4 Cr	30.4 Cr
Profit Balance B/F	-227.23 Cr	-240.28 Cr	-158.01 Cr	-168.14 Cr
Appropriations	-239.84 Cr	-158.8 Cr	-168.4 Cr	-137.74 Cr
Other Appropriation	44.11 Lk	-79.54 Lk	-26.08 Lk	59.21 Lk
Earnings Per Share	-5.04	24.94	-3.18	9.28
Adjusted EPS	-5.04	24.94	-3.18	9.28

Consolidated Standalone

CONSOLIDATED CASH FLOW FOR WANBURY LIMITED

Year End	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Profit Before Tax	-12.41 Cr	81.13 Cr	-10.29 Cr	56.34 Cr
Adjustment	33.22 Cr	-43.68 Cr	37.01 Cr	16.05 Cr
Changes In working Capital	-3 Cr	3.24 Cr	-6.75 Cr	-68.23 Cr
Cash Flow after changes in Working Capital	17.81 Cr	40.69 Cr	19.97 Cr	4.16 Cr
Cash Flow from Operating Activities	16.68 Cr	40.52 Cr	19.8 Cr	3.98 Cr
Cash Flow from Investing Activities	8.04 Cr	58.65 Lk	-8.84 Cr	-16.63 Cr
Cash Flow from Financing Activitie	-17.39 Cr	-28.58 Cr	-31.99 Cr	14.55 Cr
Net Cash Inflow / Outflow	7.34 Cr	12.52 Cr	-21.03 Cr	1.91 Cr
Opening Cash & Cash Equivalents	2.66 Cr	10 Cr	22.53 Cr	1.49 Cr
Closing Cash & Cash Equivalent	10 Cr	22.53 Cr	1.49 Cr	3.4 Cr

STANDALONE CASH FLOW FOR WANBURY LIMITED

Year End	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Profit Before Tax	-12.41 Cr	81.13 Cr	-10.29 Cr	30.78 Cr
Adjustment	33.22 Cr	-43.68 Cr	37.01 Cr	41.61 Cr
Changes In working Capital	-3 Cr	3.24 Cr	-6.75 Cr	-68.19 Cr
Cash Flow after changes in Working Capital	17.81 Cr	40.69 Cr	19.97 Cr	4.2 Cr
Cash Flow from Operating Activities	16.68 Cr	40.52 Cr	19.8 Cr	4.02 Cr
Cash Flow from Investing Activities	8.04 Cr	58.65 Lk	-8.84 Cr	-16.63 Cr
Cash Flow from Financing Activitie	-17.39 Cr	-28.58 Cr	-31.99 Cr	14.55 Cr
Net Cash Inflow / Outflow	7.34 Cr	12.52 Cr	-21.03 Cr	1.94 Cr
Opening Cash & Cash Equivalents	2.62 Cr	9.96 Cr	22.49 Cr	1.46 Cr
Closing Cash & Cash Equivalent	9.96 Cr	22.49 Cr	1.46 Cr	3.4 Cr

Consolidated Standalone

CONSOLIDATED BALANCE SHEET FOR WANBURY LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Share Capital	25.02 Cr	32.67 Cr	32.71 Cr	32.75 Cr
Equity - Authorised	50 Cr	50 Cr	50 Cr	50 Cr
Equity - Issued	32.63 Cr	32.67 Cr	32.71 Cr	32.75 Cr
Equity Paid Up	25.02 Cr	32.67 Cr	32.71 Cr	32.75 Cr
Face Value	10	10	10	10
Total Reserves	-181.6 Cr	-57.01 Cr	-67.15 Cr	-11.64 Cr
Securities Premium	60.08 Cr	102.09 Cr	102.24 Cr	102.5 Cr
Capital Reserves	6.83 Cr	6.83 Cr	6.83 Cr	6.83 Cr
Profit & Loss Account Balance	-266 Cr	-183.73 Cr	-193.87 Cr	-138.5 Cr
General Reserves	13.24 Cr	13.24 Cr	13.24 Cr	13.24 Cr
Reserve excluding Revaluation Reserve	-181.6 Cr	-57.34 Cr	-67.27 Cr	-11.64 Cr
Revaluation reserve	0	32.77 Lk	11.74 Lk	0
Shareholder's Funds	-156.24 Cr	-23.42 Cr	-32.82 Cr	27.94 Cr
Secured Loans	71.99 Cr	0	0	82 Cr
Non Convertible Debentures	0	0	0	95 Cr
Term Loans - Banks	22.85 Cr	0	-4.04 Cr	0
Term Loans - Institutions	132.9 Cr	53.82 Cr	54.98 Cr	0
Deferred Tax Assets / Liabilities	-5.63 Cr	-5.63 Cr	-5.5 Cr	-5.5 Cr
Deferred Tax Assets	5.63 Cr	5.63 Cr	5.5 Cr	5.5 Cr
Other Long Term Liabilities	4.32 Cr	4.13 Cr	2.38 Cr	3.93 Cr
Long Term Provisions	13.75 Cr	12.07 Cr	13.93 Cr	15.51 Cr
Total Non-Current Liabilities	84.43 Cr	10.56 Cr	10.81 Cr	95.95 Cr
Trade Payables	133.77 Cr	191.61 Cr	148.47 Cr	162.75 Cr
Sundry Creditors	133.77 Cr	191.61 Cr	148.47 Cr	162.75 Cr
Other Current Liabilities	200.56 Cr	150.3 Cr	154.53 Cr	33.36 Cr
Advances received from customers	3.33 Cr	14.93 Cr	9.28 Cr	2.78 Cr
Interest Accrued But Not Due	27.15 Cr	2.37 Cr	6.67 Cr	0
Short Term Borrowings	16.42 Cr	13.21 Cr	13.19 Cr	14.95 Cr
Secured ST Loans repayable on Demands	15.92 Cr	12.7 Cr	12.69 Cr	14.95 Cr
Working Capital Loans- Sec	14.4 Cr	9.84 Cr	5.97 Cr	8.33 Cr
Short Term Provisions	4.6 Cr	4.66 Cr	4.19 Cr	3.04 Cr
Provision for Tax	1.85 Cr	1.69 Cr	1.51 Cr	0
Total Current Liabilities	355.35 Cr	359.77 Cr	320.38 Cr	214.11 Cr
Total Liabilities	283.54 Cr	346.92 Cr	298.37 Cr	337.99 Cr
Gross Block	215.98 Cr	226.95 Cr	239.29 Cr	248.41 Cr
Less: Accumulated Depreciation	48.59 Cr	59.84 Cr	72.18 Cr	81.58 Cr
Net Block	167.38 Cr	167.11 Cr	167.11 Cr	166.82 Cr
Capital Work in Progress	11.01 Cr	2.35 Cr	1.61 Cr	3.01 Cr
Non Current Investments	1.32 Lk	93,000	1.44 Lk	2.55 Lk
Long Term Investment	1.32 Lk	93,000	1.44 Lk	2.55 Lk
Quoted	1.22 Lk	83,000	1.34 Lk	0
Unquoted	10,000	10,000	10,000	2.55 Lk
Long Term Loans & Advances	3.4 Cr	3.8 Cr	5.03 Cr	5.42 Cr
Other Non Current Assets	46.37 Lk	44.46 Lk	49 Lk	3.44 Cr
Total Non-Current Assets	182.28 Cr	173.71 Cr	174.24 Cr	178.71 Cr
Unquoted	10,000	10,000	10,000	2.55 Lk
Inventories	24.85 Cr	49.73 Cr	21.99 Cr	36.02 Cr
Raw Materials	8.98 Cr	9 Cr	10.41 Cr	20.5 Cr
Work-in Progress	2.65 Cr	7.52 Cr	5.53 Cr	5.84 Cr
Finished Goods	2.39 Cr	14.54 Cr	69.03 Lk	2.71 Cr
Sundry Debtors	34.47 Cr	62.8 Cr	67.98 Cr	89.44 Cr
Debtors more than Six months	0	2.39 Cr	2.27 Cr	4.85 Cr
Debtors Others	39.04 Cr	62.62 Cr	67.82 Cr	87.05 Cr
Cash and Bank	11.7 Cr	25.31 Cr	3.93 Cr	5.9 Cr
Cash in hand	3.02 Lk	4.71 Lk	5.85 Lk	12.57 Lk
Balances at Bank	11.67 Cr	25.27 Cr	3.87 Cr	5.77 Cr
Other Current Assets	26.82 Cr	31.24 Cr	4.97 Cr	6.65 Cr
Interest accrued on Investments	27,000	3.24 Lk	4.92 Lk	10.58 Lk
Prepaid Expenses	86.69 Lk	1.97 Cr	2.1 Cr	5.73 Cr
Short Term Loans and Advances	3.42 Cr	2.16 Cr	23.29 Cr	21.27 Cr
Advances recoverable in cash or in kind	81.01 Cr	80.02 Cr	80.63 Cr	39.36 Cr
Total Current Assets	101.27 Cr	171.24 Cr	122.16 Cr	159.29 Cr
Net Current Assets (Including Current Investments)	-254.09 Cr	-188.53 Cr	-198.22 Cr	-54.82 Cr
Total Assets	283.54 Cr	346.92 Cr	298.37 Cr	337.99 Cr
Contingent Liabilities	889.25 Cr	907.4 Cr	1071.74 Cr	60.04 Cr
Total Debt	130.3 Cr	67.02 Cr	64.14 Cr	109.95 Cr
Book Value	-62.6	0	-10.57	6.44
Adjusted Book Value	-62.6	-7.55	-10.57	6.44

STANDALONE BALANCE SHEET FOR WANBURY LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Share Capital	25.02 Cr	32.67 Cr	32.71 Cr	32.75 Cr
Equity - Authorised	50 Cr	50 Cr	50 Cr	50 Cr
Equity - Issued	32.63 Cr	32.67 Cr	32.71 Cr	32.75 Cr
Equity Paid Up	25.02 Cr	32.67 Cr	32.71 Cr	32.75 Cr
Face Value	10	10	10	10
Total Reserves	-156.01 Cr	-31.4 Cr	-41.6 Cr	-11.64 Cr
Securities Premium	60.08 Cr	102.09 Cr	102.24 Cr	102.5 Cr
Capital Reserves	6.83 Cr	6.83 Cr	6.83 Cr	6.83 Cr
Profit & Loss Account Balance	-240.28 Cr	-158.01 Cr	-168.14 Cr	-138.34 Cr
General Reserves	13.24 Cr	13.24 Cr	13.24 Cr	13.24 Cr
Reserve excluding Revaluation Reserve	-156.01 Cr	-31.73 Cr	-41.71 Cr	-11.64 Cr
Revaluation reserve	0	32.77 Lk	11.74 Lk	0
Shareholder's Funds	-130.66 Cr	2.19 Cr	-7.26 Cr	27.94 Cr
Secured Loans	71.99 Cr	0	0	82 Cr
Non Convertible Debentures	0	0	0	95 Cr
Term Loans - Banks	22.85 Cr	0	-4.04 Cr	0
Term Loans - Institutions	132.9 Cr	53.82 Cr	54.98 Cr	0
Deferred Tax Assets / Liabilities	-5.63 Cr	-5.63 Cr	-5.5 Cr	-5.5 Cr
Deferred Tax Assets	5.63 Cr	5.63 Cr	5.5 Cr	5.5 Cr
Other Long Term Liabilities	4.32 Cr	4.13 Cr	2.38 Cr	3.93 Cr
Long Term Provisions	13.75 Cr	12.07 Cr	13.93 Cr	15.51 Cr
Total Non-Current Liabilities	84.43 Cr	10.56 Cr	10.81 Cr	95.95 Cr
Trade Payables	133.27 Cr	191.13 Cr	147.96 Cr	162.75 Cr
Sundry Creditors	133.27 Cr	191.13 Cr	147.96 Cr	162.75 Cr
Other Current Liabilities	173.89 Cr	123.63 Cr	127.85 Cr	33.36 Cr
Advances received from customers	3.32 Cr	14.92 Cr	9.27 Cr	2.78 Cr
Interest Accrued But Not Due	27.15 Cr	2.37 Cr	6.67 Cr	0
Short Term Borrowings	16.42 Cr	13.21 Cr	13.19 Cr	14.95 Cr
Secured ST Loans repayable on Demands	15.92 Cr	12.7 Cr	12.69 Cr	14.95 Cr
Working Capital Loans- Sec	14.4 Cr	9.84 Cr	5.97 Cr	8.33 Cr
Short Term Provisions	4.6 Cr	4.66 Cr	4.19 Cr	3.04 Cr
Provision for Tax	1.85 Cr	1.69 Cr	1.51 Cr	0
Total Current Liabilities	328.19 Cr	332.62 Cr	293.19 Cr	214.11 Cr
Total Liabilities	281.97 Cr	345.37 Cr	296.74 Cr	337.99 Cr
Gross Block	215.98 Cr	226.95 Cr	239.29 Cr	248.41 Cr
Less: Accumulated Depreciation	48.59 Cr	59.84 Cr	72.18 Cr	81.58 Cr
Net Block	167.38 Cr	167.11 Cr	167.11 Cr	166.82 Cr
Capital Work in Progress	11.01 Cr	2.35 Cr	1.61 Cr	3.01 Cr
Non Current Investments	1.32 Lk	93,000	1.44 Lk	2.55 Lk
Long Term Investment	1.32 Lk	93,000	1.44 Lk	2.55 Lk
Quoted	1.22 Lk	83,000	1.34 Lk	2.45 Lk
Unquoted	10,000	10,000	10,000	10,000
Long Term Loans & Advances	3.4 Cr	3.8 Cr	5.03 Cr	5.42 Cr
Other Non Current Assets	46.37 Lk	44.46 Lk	49 Lk	3.44 Cr
Total Non-Current Assets	182.28 Cr	173.71 Cr	174.24 Cr	178.71 Cr
Unquoted	10,000	10,000	10,000	10,000
Inventories	24.85 Cr	49.73 Cr	21.99 Cr	36.02 Cr
Raw Materials	8.98 Cr	9 Cr	10.41 Cr	20.5 Cr
Work-in Progress	2.65 Cr	7.52 Cr	5.53 Cr	5.84 Cr
Finished Goods	2.39 Cr	14.54 Cr	69.03 Lk	2.71 Cr
Sundry Debtors	34.47 Cr	62.8 Cr	67.98 Cr	89.44 Cr
Debtors more than Six months	0	2.39 Cr	2.27 Cr	4.85 Cr
Debtors Others	39.04 Cr	62.62 Cr	67.82 Cr	87.05 Cr
Cash and Bank	11.66 Cr	25.27 Cr	3.89 Cr	5.9 Cr
Cash in hand	3.02 Lk	4.71 Lk	5.85 Lk	12.57 Lk
Balances at Bank	11.63 Cr	25.23 Cr	3.83 Cr	5.77 Cr
Other Current Assets	26.82 Cr	31.24 Cr	4.97 Cr	6.65 Cr
Interest accrued on Investments	27,000	3.24 Lk	4.92 Lk	10.58 Lk
Prepaid Expenses	86.69 Lk	1.97 Cr	2.1 Cr	5.73 Cr
Short Term Loans and Advances	1.88 Cr	64.96 Lk	21.7 Cr	21.27 Cr
Advances recoverable in cash or in kind	78.28 Cr	75.84 Cr	77.85 Cr	39.36 Cr
Total Current Assets	99.69 Cr	169.69 Cr	120.54 Cr	159.29 Cr
Net Current Assets (Including Current Investments)	-228.5 Cr	-162.93 Cr	-172.66 Cr	-54.82 Cr
Total Assets	281.97 Cr	345.37 Cr	296.74 Cr	337.99 Cr
Contingent Liabilities	889.25 Cr	907.4 Cr	1071.74 Cr	60.04 Cr
Total Debt	130.3 Cr	67.02 Cr	64.14 Cr	109.95 Cr
Book Value	0	0	-2.75	6.44
Adjusted Book Value	-52.37	0.29	-2.75	6.44

Consolidated Standalone

FINANCIAL RATIOS (CONSOLIDATED) FOR WANBURY LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Operational & Financial Ratios
Earnings Per Share (Rs)	-5.04	24.94	-3.18	17.09
CEPS(Rs)	-1.14	28.45	0.61	21.07
Book NAV/Share(Rs)	-62.6	-7.55	-10.57	6.44
Tax Rate(%)	-1.61	-0.43	-1.06	0.68
Margin Ratios
Core EBITDA Margin(%)	3.97	6.17	4.53	12.05
EBIT Margin(%)	2.71	19.77	2.18	14.72
Pre Tax Margin(%)	-3.15	15.77	-2.02	9.7
PAT Margin (%)	-3.2	15.83	-2.04	9.63
Cash Profit Margin (%)	-0.72	18.06	0.39	11.88
Performance Ratios
ROA(%)	-4.51	25.85	-3.22	17.6
ROCE(%)	0	428.79	29.82	101.15
Asset Turnover(x)	1.41	1.63	1.58	1.83
Sales/Fixed Asset(x)	1.88	2.32	2.18	2.38
Working Capital/Sales(x)	-1.55	-2.73	-2.57	-10.6
Efficiency Ratios
Fixed Capital/Sales(x)	0.53	0.43	0.46	0.42
Receivable days	39.45	34.5	46.87	49.78
Inventory Days	17.17	26.45	25.7	18.23
Payable days	214.85	197.75	197.84	187.83
Valuation Parameters
PER(x)	-16.46	3.41	0	8.54
PCE(x)	-72.77	2.99	61.38	6.92
Price/Book(x)	-1.33	-11.25	-3.53	22.63
EV/Net Sales(x)	0.83	0.62	0.36	1.01
EV/Core EBITDA(x)	15.97	8.67	7.57	7.97
EV/EBIT(x)	30.57	3.14	16.41	6.8
EV/CE(x)	1.15	0.92	0.61	4.22
M Cap / Sales	0.53	0.54	0.24	0.83
Growth Ratio
Net Sales Growth(%)	6.82	30.23	-2.26	15.21
Core EBITDA Growth(%)	-16.93	80.29	-34.59	203.06
EBIT Growth(%)	-89.06	853.58	-89.08	669.96
PAT Growth(%)	-119.56	746.33	-112.76	638.26
EPS Growth(%)	-119.54	594.95	-112.74	637.6
Financial Stability Ratios
Total Debt/Equity(x)	-0.83	-2.72	-1.86	5.21
Current Ratio(x)	0.28	0.48	0.38	0.74
Quick Ratio(x)	0.22	0.34	0.31	0.58
Interest Cover(x)	0.46	4.94	0.52	2.93
Total Debt/Mcap(x)	0.63	0.24	0.53	0.23

FINANCIAL RATIOS (STANDALONE) FOR WANBURY LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Operational & Financial Ratios
Earnings Per Share (Rs)	-5.04	24.94	-3.18	9.28
CEPS(Rs)	-1.14	28.45	0.61	13.26
Book NAV/Share(Rs)	-52.37	0.29	-2.75	6.44
Tax Rate(%)	-1.61	-0.43	-1.06	1.24
Margin Ratios
Core EBITDA Margin(%)	3.97	6.17	4.53	12.05
EBIT Margin(%)	2.71	19.77	2.18	10.32
Pre Tax Margin(%)	-3.15	15.77	-2.02	5.3
PAT Margin (%)	-3.2	15.83	-2.04	5.23
Cash Profit Margin (%)	-0.72	18.06	0.39	7.48
Performance Ratios
ROA(%)	-4.54	25.97	-3.24	9.58
ROE(%)	0	0	0	502.76
ROCE(%)	46.95	206.26	17.68	61.61
Asset Turnover(x)	1.42	1.64	1.59	1.83
Sales/Fixed Asset(x)	1.88	2.32	2.18	2.38
Working Capital/Sales(x)	-1.73	-3.16	-2.95	-10.6
Efficiency Ratios
Fixed Capital/Sales(x)	0.53	0.43	0.46	0.42
Receivable days	39.45	34.5	46.87	49.78
Inventory Days	17.17	26.45	25.7	18.23
Payable days	214.03	197.16	197.24	187.52
Valuation Parameters
PER(x)	0	3.41	0	15.71
PCE(x)	-72.77	2.99	61.38	11
Price/Book(x)	-1.58	296.26	-13.55	22.63
EV/Net Sales(x)	0.83	0.62	0.36	1.01
EV/Core EBITDA(x)	15.97	8.67	7.57	7.97
EV/EBIT(x)	30.57	3.14	16.41	9.7
EV/CE(x)	1.16	0.92	0.61	4.22
M Cap / Sales	0.53	0.54	0.24	0.83
Growth Ratio
Net Sales Growth(%)	6.82	30.23	-2.26	15.21
Core EBITDA Growth(%)	-16.93	80.29	-34.59	203.06
EBIT Growth(%)	-89.06	853.58	-89.08	439.86
PAT Growth(%)	-119.56	746.33	-112.76	392.42
EPS Growth(%)	-119.54	594.95	-112.74	392.07
Financial Stability Ratios
Total Debt/Equity(x)	-0.99	71.51	-7.12	5.21
Current Ratio(x)	0.3	0.51	0.41	0.74
Quick Ratio(x)	0.23	0.36	0.34	0.58
Interest Cover(x)	0.46	4.94	0.52	2.05
Total Debt/Mcap(x)	0.63	0.24	0.53	0.23

SHARE HOLDING PATTERN FOR WANBURY LIMITED

Date	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters %	30.60	30.60	30.59	30.59	30.59	30.56	30.56	30.56	30.56	30.54
FII %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.18	0.22	1.02
DII %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Public %	60.15	60.15	60.16	60.16	60.16	60.20	60.21	60.03	59.98	59.20

PEER COMPARISON FOR WANBURY LIMITED

No.	Name
1	AMBALAL SARABHAI ENTERPRISES LTD
2	Cipla Limited
3	Dr. Reddy's Laboratories Limited
4	Procter & Gamble Health Limited
5	J.K.PHARMACHEM LTD
6	Lupin Limited
7	Lyka Labs Limited
8	MESCO PHARMACEUTICALS LTD
9	Morepen Laboratories Limited
10	Piramal Enterprises Limited
11	Torrent Pharmaceuticals Limited
12	Abbott India Limited
13	GlaxoSmithKline Pharmaceuticals Limited
14	Sanofi India Limited
15	Pfizer Limited
16	Bliss GVS Pharma Limited
17	Alembic Limited
18	Unichem Laboratories Limited
19	AstraZeneca Pharma India Limited
20	GUJARAT THEMIS BIOSYN LTD
21	JB Chemicals & Pharmaceuticals Limited
22	TTK Healthcare Limited
23	Jagsonpal Pharmaceuticals Limited
24	Gufic Biosciences Limited
25	Sequent Scientific Limited
26	Albert David Limited
27	IOL Chemicals and Pharmaceuticals Limited
28	Wanbury Limited
29	Kopran Limited
30	Aarti Drugs Limited
31	Orchid Pharma Limited
32	Biofil Chemicals & Pharmaceuticals Limited
33	Marksans Pharma Limited
34	IPCA Laboratories Limited
35	Kilitch Drugs (India) Limited
36	Krebs Biochemicals and Industries Limited
37	Neuland Laboratories Limited
38	Ind-Swift Limited
39	Hester Biosciences Limited
40	Parenteral Drugs (India) Limited
41	Sun Pharmaceutical Industries Limited
42	Hikal Limited
43	Caplin Point Laboratories Limited
44	Aurobindo Pharma Limited
45	Natco Pharma Limited
46	Bal Pharma Limited
47	BDH INDUSTRIES LTD
48	Venus Remedies Limited
49	Jubilant Pharmova Limited
50	Themis Medicare Limited

CORPORATE ACTIONS FOR WANBURY LIMITED

Exchange Date	Purpose	Book Closure Dates
BSE 17-Sep-2024	Book Closure - A.G.M.	21-Sep-2024 27-Sep-2024
BSE 17-Sep-2024	AGM - A.G.M.	27-Sep-2024 27-Sep-2024
BSE 06-Aug-2024	Board Meeting - Quarterly Results	12-Aug-2024
BSE 07-May-2024	Board Meeting - Audited Results	16-May-2024
BSE 12-Jan-2024	Board Meeting - Quarterly Results	24-Jan-2024
BSE 27-Oct-2023	Book Closure - E.G.M.	11-Nov-2023 18-Nov-2023
BSE 12-Oct-2023	Board Meeting - Quarterly Results	20-Oct-2023
BSE 18-Sep-2023	Book Closure - A.G.M.	21-Sep-2023 27-Sep-2023
BSE 18-Sep-2023	AGM - A.G.M.	27-Sep-2023 27-Sep-2023
BSE 02-Aug-2023	Book Closure - E.G.M.	15-Aug-2023 21-Aug-2023
BSE 01-Aug-2023	Board Meeting - Quarterly Results	11-Aug-2023
BSE 07-Jun-2023	Board Meeting - Audited Results (Revised)	26-Jun-2023
BSE 25-May-2023	Board Meeting - Audited Results	09-Jun-2023
BSE 25-May-2023	Board Meeting - Audited Results(Cancelled) (Cancelled)	30-May-2023
BSE 23-May-2023	Board Meeting - Audited Results	30-May-2023
BSE 03-Feb-2023	Board Meeting - Quarterly Results	14-Feb-2023
BSE 09-Nov-2022	Board Meeting - Quarterly Results (Revised)	28-Nov-2022
BSE 28-Oct-2022	Board Meeting - Quarterly Results	11-Nov-2022
BSE 19-Sep-2022	Book Closure - A.G.M.	22-Sep-2022 28-Sep-2022
BSE 19-Sep-2022	AGM - A.G.M.	28-Sep-2022 28-Sep-2022
BSE 29-Jul-2022	Board Meeting - Quarterly Results	10-Aug-2022
BSE 20-May-2022	Board Meeting - Audited Results	22-Jun-2022
BSE 14-Feb-2022	Board Meeting - Preferential Issue of shares Inter-alia, to consider and evaluate any and all proposals for raising of funds by way of a preferential issue/ allotment, private placement including a qualified institutions placement or foreign currency convertible bonds or tlu?ough any other permissible mode and/ or combination thereof, as may be considered appropriate, by way of issue of equity shares or warrants ...	17-Feb-2022
BSE 01-Feb-2022	Board Meeting - Quarterly Results	08-Feb-2022
BSE 10-Nov-2021	Board Meeting - Quarterly Results (Revised)	25-Nov-2021
BSE 01-Nov-2021	Board Meeting - Quarterly Results	12-Nov-2021
BSE 20-Oct-2021	Board Meeting - Quarterly Results	20-Oct-2021
BSE 13-Sep-2021	Board Meeting - WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/10/2021 ,inter alia, to consider and approve This is with reference to our earlier letter dated 3rd August, 2021 and 9th August, 2021 regarding the meeting of Board of Directors of Wanbury Limited which is scheduled to be held on 20th September, 2021 inter-alia to consider and approve the Un-A...	20-Sep-2021
BSE 02-Sep-2021	Book Closure - A.G.M.	21-Sep-2021 27-Sep-2021
BSE 02-Sep-2021	AGM - A.G.M.	27-Sep-2021 27-Sep-2021

CORPORATE ANNOUNCEMENTS FOR WANBURY LIMITED

Exchange Date	Category File	Description
BSE 22-Oct-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation towards issue of duplicate shares certificate under SEBI LODR Reg 2015.
BSE 08-Oct-2024	General Announcements FILE	Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate pursuant to Reg 74(5) of SEBI (DP) Reg 2018 for the quarter ended 30th Sept. 2024
BSE 07-Oct-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation towards issue of duplicate share certificate under regulation 39(3) of SEBI LODR Regulation 2015
BSE 28-Sep-2024	Outcome FILE	Shareholder Meeting / Postal Ballot-Scrutinizer''s Report Submission of Voting Results and Scrutinizer Report of 36th Annual General Meeting held on 27th September 2024.
BSE 27-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Directorate Appointment of Mr. Mridul Mehta as Non-executive Independent Director
BSE 27-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s Appointment of M/s. Kapoor & Parekh Associates as Statutory Auditor of the Company.
BSE 27-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Management Pursuant to Schedule III of the SEBI (LODR) read with Regulation 30 of the SEBI Listing Regulations
BSE 27-Sep-2024	Outcome FILE	Shareholder Meeting / Postal Ballot-Outcome of AGM Outcome of 36th Annual General Meeting dated 27.09.2024
BSE 25-Sep-2024	Intimation FILE	Closure of Trading Window Trading window closure for the quarter and half year ended 30.09.2024
BSE 12-Sep-2024	General Announcements FILE	Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Wanbury'S API Product Portfolio And Pipeline Disclosure under Regulation 30 of the SEBI (LODR) Regulations 2015- Wanburys API Product Portfolio and Pipeline
BSE 09-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Press Release / Media Release Press Release- Wanbury Limited received a Certificate of Suitability (CEP) for the Launch of its new product Dextromethorphan (API)
BSE 05-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Newspaper Publication Post-Dispatch Newspaper clipping for 36th Annual General Meeting
BSE 04-Sep-2024	Intimation FILE	Notice Of Book Closure For The Purpose Of 36Th Annual General Meeting (AGM) Notice of Book Closure for the purpose of 36th Annual General Meeting (AGM)
BSE 04-Sep-2024	General Announcements FILE	Reg. 34 (1) Annual Report. The 36th Annual General Meeting( AGM) of Wanbury Limited (the Company) will be held on Friday 27th September 2024 at 11.30 AM at Ebony Hall Hotel Tunga Regenza Plot No. 37 Sector 30-A Vashi Navi Mumbai - 400 703. Pursuant to Regulations 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are submitting herewith the Annual Report of the Company along with the Notice of AGM for the financial year 2023-24 which is being sent through electronic mode only to the Members of the Company.The Annual Report containing the Notice is also available on the website of the Company at www.wanbury.com.
BSE 04-Sep-2024	Intimation FILE	Annual Report 2023-24 And Notice Of The 36Th Annual General Meeting Of Wanbury Limited Annual Report 2023-24 and Notice of the 36th Annual General Meeting of Wanbury Limited
BSE 30-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Clipping Information regarding 36th Annual General Meeting to be held on Friday September 27 2024 at 11.30. a.m.
BSE 23-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Press Release / Media Release Press Release- Establishment Inspection Report ("EIR) received from US FDA at Wanbury Limiteds manufacturing facility located at Patalganaga Maharashtra
BSE 21-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Press Release / Media Release Wanbury Limited wins two Safety Awards for its API Manufacturing site in Patalganga for the third consecutive year at the Maharashtra Safety Awards Competition 2023 conducted by Maharashtra State Government
BSE 20-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Press Release / Media Release Press release on Q1FY25 Financial Results
BSE 20-Aug-2024	General Announcements FILE	Intimation Of Appointment Of CEO Of India Formulation Business Under Regulation 30 Of SEBI (LODR) Regulations 2015 Intimation of Appointment of CEO of India Formulation Business under Regulation 30 of SEBI (LODR) Regulations 2015
BSE 20-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Press Release / Media Release Intimation of Appointment of CEO of India Formulation Business under Regulation 30 of SEBI (LODR) Regulations 2015
BSE 13-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Directorate Appointment of an Additional Non-Exceutive Independent Director
BSE 13-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s Appointment of Statutory Auditors
BSE 13-Aug-2024	General Announcements FILE	Intimation Of Appointment Of President Of API Business Under Regulation 30 Of SEBI (LODR) Regulations 2015 Intimation of Appointment of President of API Business under Regulation 30 of SEBI (LODR) Regulations 2015
BSE 12-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors Change in Management due to Resignation of Statutory Auditor
BSE 12-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Management Change in Management due to Appointment and Resignation of Auditor and Appointment of an Additional Non-Executive Independent Director
BSE 12-Aug-2024	Outcome FILE	Outcome Of The Board Meeting Held On August 12 2024 Financial Results for the Board Meeting held on 12th August 2024
BSE 12-Aug-2024	Outcome FILE	Board Meeting Outcome for Outcome Of The Board Meeting Held On August 12 2024 Outcome of the Board Meeting held on August 12 2024
BSE 06-Aug-2024	Intimation FILE	Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the meeting of the Board of Directors of Wanbury Limited is scheduled to be held on Monday August 12 2024 inter-alia to consider and approve the following: 1. Un-audited Financial Results (Standalone & Consolidated) for the first quarter and three months ended June 30 2024.Further as per Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 the trading window for dealing in Securities of the Company shall remain closed for the Companys Directors/Officers/Key Managerial Personnel/Designated Employees of the Company until the expiry of 48 hours after the declaration of the said Financial Results.The intimation is also available on the website of the Company at www.wanbury.com and on the website of BSE Limited at www.bseindia.com and the National Stock Exchange of India Limited at www.nseindia.com.
BSE 03-Jul-2024	General Announcements FILE	Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

INSIDER TRADING FOR WANBURY LIMITED

Exchange Dates	Activity	Qty & Price (%)	Person / Organisation
BSE 15-May-2024 15-May-2024	Buy Creation Of Pledge	85,000 @ 0.00 (0.01 %)	SBICAP Trustee Cumpany Ltd
BSE 08-Apr-2024 08-Apr-2024	Buy Creation Of Pledge	740,743 @ 0.00 (2.26 %)	SBICAP trustee Company Ltd
BSE 21-Mar-2024 21-Mar-2024	Buy Preferential Offer	2,000,000 @ 0.00 (3.99 %)	Expert Chemicals India Pvt Ltd
BSE 24-Aug-2023 24-Aug-2023	Buy Creation Of Pledge	5,925,230 @ 0.00 (18.12 %)	SBICAP Trustee Company Ltd

BULK BLOCK DEALS FOR WANBURY LIMITED

Exchange Dates	Activity	Qty & Price (%)	Person / Organisation
BSE 04-May-2023	Buy BULK	219,753 @ 52.70	GANITA TECHNOLOGIES AND SERVICES PRIVATE LIMITED
BSE 21-Apr-2023	Sell BULK	196,000 @ 38.00	RASHI FINCORP LIMITED

DIVIDEND BY WANBURY LIMITED

No dividend details found

SPLIT / BONUS BY WANBURY LIMITED

No Split / Bonus details found

Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed

Facebook

Twitter

To TOP

Wanbury Limited

Wanbury Limited share price

CONSOLIDATED QUARTERLY RESULT FOR WANBURY LIMITED

STANDALONE QUARTERLY RESULT FOR WANBURY LIMITED

CONSOLIDATED ANNUAL RESULT FOR WANBURY LIMITED

STANDALONE ANNUAL RESULT FOR WANBURY LIMITED

CONSOLIDATED PROFIT / LOSS FOR WANBURY LIMITED

STANDALONE PROFIT / LOSS FOR WANBURY LIMITED

CONSOLIDATED CASH FLOW FOR WANBURY LIMITED

STANDALONE CASH FLOW FOR WANBURY LIMITED

CONSOLIDATED BALANCE SHEET FOR WANBURY LIMITED

STANDALONE BALANCE SHEET FOR WANBURY LIMITED

FINANCIAL RATIOS (CONSOLIDATED) FOR WANBURY LIMITED

FINANCIAL RATIOS (STANDALONE) FOR WANBURY LIMITED

SHARE HOLDING PATTERN FOR WANBURY LIMITED

PEER COMPARISON FOR WANBURY LIMITED

CORPORATE ACTIONS FOR WANBURY LIMITED

CORPORATE ANNOUNCEMENTS FOR WANBURY LIMITED

INSIDER TRADING FOR WANBURY LIMITED

BULK BLOCK DEALS FOR WANBURY LIMITED

DIVIDEND BY WANBURY LIMITED

SPLIT / BONUS BY WANBURY LIMITED